FT US Pharma and Biotech Summit 2025: Live coverage

We’re back this year, this time virtually attending the FT US Pharma and Biotech Summit in New York City, a one-day event where top pharma execs will come together to discuss the major trends impacting the industry today – and, boy, are there some big trends to discuss this year.

The event will include keynote interviews with Bristol-Myers Squibb Board Chair and CEO Christopher Boerner, Lilly SVP of neuroscience Laura Steele, Retro Biosciences CEO Joe Betts-LaCroix, and White House Special Government Employee Calley Means.

Speaking of the White House, there will be several sessions dedicated to unpacking the many effects of Donald Trump’s second presidential term on the pharmaceutical industry, including a deep dive into US-Chinese relations and the role biopharma plays.

Other sessions will tackle drug pricing and access, the burgeoning longevity market, the biopharma workforce and, of course, AI.

Tune in throughout the day for summaries and key takeaways from this important meeting of the minds.